These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 25469790)

  • 1. Anti-adipocyte antibody response in patients with non-alcoholic fatty liver disease.
    Karrar A; Stepanova M; Alaparthi L; Lingam S; Younoszai Z; Zheng L; Malik KS; Younossi E; Monge F; Hunt SL; Goodman Z; Younossi ZM
    J Gastroenterol Hepatol; 2015 May; 30(5):900-8. PubMed ID: 25469790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low levels of IgM antibodies recognizing oxidation-specific epitopes are associated with human non-alcoholic fatty liver disease.
    Hendrikx T; Watzenböck ML; Walenbergh SM; Amir S; Gruber S; Kozma MO; Grabsch HI; Koek GH; Pierik MJ; Staufer K; Trauner M; Kalhan SC; Jonkers D; Hofker MH; Binder CJ; Shiri-Sverdlov R
    BMC Med; 2016 Jul; 14(1):107. PubMed ID: 27443391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum immunoglobulin levels predict fibrosis in patients with non-alcoholic fatty liver disease.
    McPherson S; Henderson E; Burt AD; Day CP; Anstee QM
    J Hepatol; 2014 May; 60(5):1055-62. PubMed ID: 24445215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidized low-density lipoprotein antibodies/high-density lipoprotein cholesterol ratio is linked to advanced non-alcoholic fatty liver disease lean patients.
    Ampuero J; Ranchal I; Gallego-Durán R; Pareja MJ; Del Campo JA; Pastor-Ramírez H; Rico MC; Picón R; Pastor L; García-Monzón C; Andrade R; Romero-Gómez M
    J Gastroenterol Hepatol; 2016 Sep; 31(9):1611-8. PubMed ID: 26946071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Adipose Tissue Inflammation With Histologic Severity of Nonalcoholic Fatty Liver Disease.
    du Plessis J; van Pelt J; Korf H; Mathieu C; van der Schueren B; Lannoo M; Oyen T; Topal B; Fetter G; Nayler S; van der Merwe T; Windmolders P; Van Gaal L; Verrijken A; Hubens G; Gericke M; Cassiman D; Francque S; Nevens F; van der Merwe S
    Gastroenterology; 2015 Sep; 149(3):635-48.e14. PubMed ID: 26028579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HCV genotype 3 and squamous cell carcinoma antigen (SCCA)-IgM are independently associated with histological features of NASH in HCV-infected patients.
    Martini A; Fattovich G; Guido M; Bugianesi E; Biasiolo A; Ieluzzi D; Gallotta A; Fassina G; Merkel C; Gatta A; Negro F; Pontisso P
    J Viral Hepat; 2015 Oct; 22(10):800-8. PubMed ID: 25611978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single non-invasive model to diagnose non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH).
    Otgonsuren M; Estep MJ; Hossain N; Younossi E; Frost S; Henry L; Hunt S; Fang Y; Goodman Z; Younossi ZM
    J Gastroenterol Hepatol; 2014 Dec; 29(12):2006-13. PubMed ID: 25039333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive value of ALT levels for non-alcoholic steatohepatitis (NASH) and advanced fibrosis in non-alcoholic fatty liver disease (NAFLD).
    Verma S; Jensen D; Hart J; Mohanty SR
    Liver Int; 2013 Oct; 33(9):1398-405. PubMed ID: 23763360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum levels of immunoglobulins in an adult population and their relationship with nonalcoholic fatty liver disease.
    Sun SM; Wang YY; Zhang Q; Liu L; Meng G; Yao ZX; Wu HM; Xia Y; Bao X; Gu YQ; Wang HL; Shi HB; Xu HY; Wang X; Zhou M; Jiao HL; Jia QY; Wang BM; Niu KJ
    J Dig Dis; 2018 Aug; 19(8):498-507. PubMed ID: 29989347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Helicobacter pylori infection in patients with nonalcoholic fatty liver disease.
    Polyzos SA; Kountouras J; Papatheodorou A; Patsiaoura K; Katsiki E; Zafeiriadou E; Zavos C; Anastasiadou K; Terpos E
    Metabolism; 2013 Jan; 62(1):121-6. PubMed ID: 22841522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-alcoholic fatty liver disease: spectral patterns observed from an in vivo phosphorus magnetic resonance spectroscopy study.
    Abrigo JM; Shen J; Wong VW; Yeung DK; Wong GL; Chim AM; Chan AW; Choi PC; Chan FK; Chan HL; Chu WC
    J Hepatol; 2014 Apr; 60(4):809-15. PubMed ID: 24291241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum immunoglobulins (IgG, IgA, IgM) in chronic hepatitis C. A comparison with non-cirrhotic alcoholic liver disease.
    Gonzàlez-Quintela A; Alende MR; Gamallo R; Gonzàlez-Gil P; López-Ben S; Tomé S; Otero E; Torre JA
    Hepatogastroenterology; 2003; 50(54):2121-6. PubMed ID: 14696478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progression of liver disease in non-alcoholic fatty liver disease: a prospective clinicopathological follow-up study.
    Chan WK; Ida NH; Cheah PL; Goh KL
    J Dig Dis; 2014 Oct; 15(10):545-52. PubMed ID: 25060399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship of serum uric acid with non-alcoholic fatty liver disease.
    Sertoglu E; Ercin CN; Celebi G; Gurel H; Kayadibi H; Genc H; Kara M; Dogru T
    Clin Biochem; 2014 Apr; 47(6):383-8. PubMed ID: 24525254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Helicobacter pylori infection might have a potential role in hepatocyte ballooning in nonalcoholic fatty liver disease.
    Sumida Y; Kanemasa K; Imai S; Mori K; Tanaka S; Shimokobe H; Kitamura Y; Fukumoto K; Kakutani A; Ohno T; Taketani H; Seko Y; Ishiba H; Hara T; Okajima A; Yamaguchi K; Moriguchi M; Mitsuyoshi H; Yasui K; Minami M; Itoh Y
    J Gastroenterol; 2015 Sep; 50(9):996-1004. PubMed ID: 25622927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unconjugated hyperbilirubinemia is inversely associated with non-alcoholic steatohepatitis (NASH).
    Hjelkrem M; Morales A; Williams CD; Harrison SA
    Aliment Pharmacol Ther; 2012 Jun; 35(12):1416-23. PubMed ID: 22540836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombotic risk factors and liver histologic lesions in non-alcoholic fatty liver disease.
    Papatheodoridis GV; Chrysanthos N; Cholongitas E; Pavlou E; Apergis G; Tiniakos DG; Andrioti E; Theodossiades G; Archimandritis AJ
    J Hepatol; 2009 Nov; 51(5):931-8. PubMed ID: 19726097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical and histological features of non-alcoholic fatty liver disease].
    Shi JP; Xun YH; Hu CB; Zhang L; Liu H; Lou GQ; Fan JG
    Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):812-6. PubMed ID: 19958638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased immunoexpression of survivin could be a potential marker in human non-alcoholic fatty liver disease progression?
    Stefano JT; de Oliveira CP; Corrêa-Giannella ML; Soares IC; Kubrusly MS; Bellodi-Privato M; de Mello ES; de Lima VM; Carrilho FJ; Alves VA
    Liver Int; 2011 Mar; 31(3):377-85. PubMed ID: 21108736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum intercellular adhesion molecule-1 in patients with nonalcoholic steatohepatitis: comparison with alcoholic hepatitis.
    Ito S; Yukawa T; Uetake S; Yamauchi M
    Alcohol Clin Exp Res; 2007 Jan; 31(1 Suppl):S83-7. PubMed ID: 17331172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.